期刊
CELL DEATH & DISEASE
卷 3, 期 -, 页码 -出版社
SPRINGERNATURE
DOI: 10.1038/cddis.2012.13
关键词
lymphoma; adenosine monophosphate-activated kinase; mammalian target of rapamycin; metformin; drug sensitivity; autophagy
类别
资金
- National Natural Science Foundation of China [81172254]
- Shanghai Commission of Science and Technology [11JC1407300]
- 'Shu Guang' project
- Shanghai Municipal Education Commission
- Shanghai Education Development Foundation [09SG21]
Adenosine monophosphate-activated protein kinase (AMPK) acts as a major sensor of cellular energy status in cancers and is critically involved in cell sensitivity to anticancer agents. Here, we showed that AMPK was inactivated in lymphoma and related to the upregulation of the mammalian target of rapamycin (mTOR) pathway. AMPK activator metformin potentially inhibited the growth of B-and T-lymphoma cells. Strong antitumor effect was also observed on primary lymphoma cells while sparing normal hematopoiesis ex vivo. Metformin-induced AMPK activation was associated with the inhibition of the mTOR signaling without involving AKT. Moreover, lymphoma cell response to the chemotherapeutic agent doxorubicin and mTOR inhibitor temsirolimus was significantly enhanced when co-treated with metformin. Pharmacologic and molecular knock-down of AMPK attenuated metformin-mediated lymphoma cell growth inhibition and drug sensitization. In vivo, metformin induced AMPK activation, mTOR inhibition and remarkably blocked tumor growth in murine lymphoma xenografts. Of note, metformin was equally effective when given orally. Combined treatment of oral metformin with doxorubicin or temsirolimus triggered lymphoma cell autophagy and functioned more efficiently than either agent alone. Taken together, these data provided first evidence for the growth-inhibitory and drug-sensitizing effect of metformin on lymphoma. Selectively targeting mTOR pathway through AMPK activation may thus represent a promising new strategy to improve treatment of lymphoma patients. Cell Death and Disease (2012) 3, e275; doi:10.1038/cddis.2012.13; published online 1 March 2012
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据